++
For further information, see CMDT PART 6-12: Basal Cell Carcinoma
+++
Essentials of Diagnosis
++
Pearly papule, erythematous patch > 6 mm, or nonhealing ulcer, in sun-exposed areas (face, trunk, lower legs)
History of bleeding
Fair-skinned person with a history of sun exposure (often intense, intermittent)
+++
General Considerations
++
Most common form of cancer
Occurs on sun-exposed skin in otherwise normal fair-skinned individuals; ultraviolet light is the cause
Can be divided into clinical and histologic subtypes, which determine both clinical behavior and treatment
Clinical subtypes: superficial, nodular, pigmented, and morpheaform
Histologic subtypes: superficial, nodular, micronodular, and infiltrative
Morpheaform, micronodular and infiltrative basal cell carcinomas
Clinicians should examine the whole skin routinely, looking for bumps, patches, and scabbed lesions
++
Most common presentation is a papule or nodule that may have a scab or erosion
Occasionally, the nodules have a brown-gray color or have stippled pigment (pigmented basal cell carcinoma)
Lesions grow slowly, attaining a size of 1–2 cm or more in diameter, usually only after years of growth
There is a waxy, "pearly" appearance, with telangiectatic vessels easily visible
Pearly or translucent quality of the lesions is most diagnostic, a feature best appreciated if the skin is stretched
On the back and chest and lower legs, basal cell carcinomas appear as reddish, somewhat shiny, scaly plaques
Morpheaform basal cell carcinomas are scar-like in appearance
When examining the face, look at the eyelid margins and medial canthi, the nose and alar folds, the lips, and then around and behind the ears
+++
Differential Diagnosis
++
Squamous cell carcinoma
Actinic keratosis
Intradermal nevus
Fibrous papule of the nose
Seborrheic keratosis (unpigmented type)
Sebaceous (epidermal inclusion) cyst
Sebaceous hyperplasia
Keratoacanthoma
Molluscum contagiosum
Melanoma
Paget disease
+++
Diagnostic Procedures
++
Lesions suspected to be basal cell carcinomas should be biopsied, by shave or punch biopsy
Biopsy confirms the diagnosis
++
Imiquimod (applied topically 5 nights per week for 6–10 weeks depending on patient reaction) and 5-fluorouracil (applied topically twice daily for up to 12 weeks)
May be appropriate for select patients with superficial basal cell carcinomas
However, the treated area must be observed for evidence of complete cure
Hedgehog pathway inhibitors (vismodegib, sonidegib) are reserved for the treatment of advanced or metastatic basal cell carcinoma or in patients with extensive tumor burden (eg, basal cell nevus syndrome)
++